4,620
views
0
recommends
+1 Recommend
1 collections
    6
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Increased Age-adjusted Cancer Mortality after the 3rd mRNA-Lipid Nanoparticle Vaccine Dose during the COVID-19 Pandemic in Japan

      preprint
      1 , 2 , 3 , 4 , 4
      5 (Editor)
      Zenodo
      Age-adjusted Mortality, Cancer, mRNA-Lipid Nanoparticle Vaccine, COVID-19, Japan
      Overview Bookmark

            Abstract

            Abstract Purpose: Excess deaths during the COVID-19 pandemic have become an issue in Japan, which has a rapidly aging population, and we conducted this study to evaluate how age-adjusted mortality rates for individual cancers shifted during the pandemic. Methods: Using published national data, we compared age-adjusted mortality rates for each cancer type between the first 3 years of the pandemic (2020-2022) and the 3 years before the pandemic (2017-2019), and also compared mortality rates in 2022 after nationwide mRNA-LNP vaccination to rates in 2020 before vaccination began. In addition, we identified trends in mortality from 2012 to 2019 to assess excess/deficit mortality during the pandemic. Results: Age-adjusted mortality rates decreased from the pre-pandemic period to the pandemic period for stomach, liver, lung, gallbladder/biliary tract, colon, and esophageal cancers, which account for a large proportion of cancer deaths in Japan, but this decreasing trend slowed from 2021 to 2022. Age-adjusted mortality rates for breast, pancreatic, lip/oral/pharyngeal cancers and leukemia increased significantly in 2022 after much of the Japanese population had received the third mRNA-LNP vaccine dose, compared to 2020, the first year of the pandemic when no vaccinations were administered. There were also marginally significant increases for ovarian and uterine cancers between 2020 and 2022. Data interpretations: As previously described in a molecular biological study, the increased mortality rates for these cancers might be caused by cell proliferation mediated by binding of spike protein to estrogen receptors, and the spike protein might originate from mRNA-LNP vaccination rather than COVID-19 infection itself. The significance of this possibility warrants further studies.

            Author and article information

            Journal
            Zenodo
            2023
            18 September 2023
            Affiliations
            [1 ] Matsubara Clinic
            [2 ] Nagoya Pediatric Cancer Fund
            [3 ] Honbetsu Cardiovascular Medicine Clinic
            [4 ] Learning Health Society Institute
            [5 ] MCL Corporation
            Author information
            https://orcid.org/0009-0002-3167-2304
            https://orcid.org/0000-0003-4125-5467
            https://orcid.org/0009-0009-0483-505X
            https://orcid.org/0000-0002-5456-3891
            Article
            10.5281/zenodo.8352450
            1edb5467-679a-4852-a402-9edf1693283a

            Creative Commons Attribution 4.0 International

            History

            Age-adjusted Mortality,mRNA-Lipid Nanoparticle Vaccine,COVID-19,Japan,Cancer

            Comments

            Comment on this article